the advent of new drugs has led to a dramatic change in the management of rheumatic diseases in children. Central to this, is the development of a new class of agents termed biologics, which has ...

Currently, there’s only one type of medication — a class of drugs called biologics — that’s approved ... But adding HS to the indication list has been groundbreaking for the treatment ...

The design of the study that evaluated etanercept's effectiveness in JIA has become the model for subsequent studies of biologic agents in children. [8] Children with JIA refractory or intolerant ...